Management of Hypnotic Discontinuation in Chronic Insomnia

Cognitive behavioral therapy aided discontinuation of benzodiazepine in chronic insomnia.

P a t i e n t s 65 patients ≥ 50 years of age (mean age 67 y, 58% women) with chronic insomnia (> 6 mo) who had impaired daytime functioning or mood disturbances, had been taking a benzodiazepine nightly for ≥ 3 months, and were unable to refrain from taking a hypnotic for fear of poor sleep, or reported sleep efficiency (total sleep time/time in bed × 100) < 80% over a 2-week period. Exclusion...

Cognitive behavioural therapy improved benzodiazepine discontinuation in chronic insomnia.

Baillargeon L, Landreville P, Verreault R, et al. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ 2003;169:1015–20. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....

Newer hypnotic drugs for the short-term management of insomnia

Nonpharmacologic Management of Chronic Insomnia.

Insomnia affects 10% to 30% of the population with a total cost of $92.5 to $107.5 billion annually. Short-term, chronic, and other types of insomnia are the three major categories according to the International Classification of Sleep Disorders, 3rd ed. The criteria for diagnosis are difficulty falling asleep, difficulty staying asleep, or early awakening despite the opportunity for sleep; sym...

Hypnotic Effect of Salvia reuterana Boiss for Treatment of Insomnia

Background: Insomnia, which is difficulty in initiating and maintaining sleep, is a very common experience for many people. Considering the increasing interest in medicinal plants in the past decade, many plants such as Coriandrum sativum, Salvia leriifolia, Salvia reuterana and Stachys lavanduli folia have been used in Iranian traditional medicine to abate insomnia. Objective: The present stu...